Methanesulfonyl Fluoride

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Methanesulfonyl Fluoride
Accession Number
DB13058
Type
Small Molecule
Groups
Investigational
Description

Methanesulfonyl Fluoride has been used in trials studying the treatment of Safety.

Structure
Thumb
Synonyms
Not Available
External IDs
SNX-001
Categories
UNII
9H250YYY0R
CAS number
558-25-8
Weight
Average: 98.09
Monoisotopic: 97.983778674
Chemical Formula
CH3FO2S
InChI Key
KNWQLFOXPQZGPX-UHFFFAOYSA-N
InChI
InChI=1S/CH3FO2S/c1-5(2,3)4/h1H3
IUPAC Name
methanesulfonyl fluoride
SMILES
CS(F)(=O)=O

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Additional Data Available
Adverse Effects

Comprehensive structured data on known drug adverse effects with statistical prevalence. MedDRA and ICD10 ids are provided for adverse effect conditions and symptoms.

Learn more
Additional Data Available
Contraindications

Structured data covering drug contraindications. Each contraindication describes a scenario in which the drug is not to be used. Includes restrictions on co-administration, contraindicated populations, and more.

Learn more
Additional Data Available
Blackbox Warnings

Structured data representing warnings from the black box section of drug labels. These warnings cover important and dangerous risks, contraindications, or adverse effects.

Learn more
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteraction
AclidiniumThe therapeutic efficacy of Aclidinium can be decreased when used in combination with Methanesulfonyl Fluoride.
AgmatineThe therapeutic efficacy of Agmatine can be decreased when used in combination with Methanesulfonyl Fluoride.
AlcuroniumThe therapeutic efficacy of Alcuronium can be decreased when used in combination with Methanesulfonyl Fluoride.
AmikacinThe therapeutic efficacy of Methanesulfonyl Fluoride can be decreased when used in combination with Amikacin.
AmitriptylineThe therapeutic efficacy of Amitriptyline can be decreased when used in combination with Methanesulfonyl Fluoride.
AmobarbitalThe therapeutic efficacy of Amobarbital can be decreased when used in combination with Methanesulfonyl Fluoride.
AmoxapineThe therapeutic efficacy of Amoxapine can be decreased when used in combination with Methanesulfonyl Fluoride.
Anisotropine methylbromideThe therapeutic efficacy of Anisotropine methylbromide can be decreased when used in combination with Methanesulfonyl Fluoride.
ApramycinThe therapeutic efficacy of Methanesulfonyl Fluoride can be decreased when used in combination with Apramycin.
AprobarbitalThe therapeutic efficacy of Aprobarbital can be decreased when used in combination with Methanesulfonyl Fluoride.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Evidence Level

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

References

General References
Not Available
External Links
PubChem Compound
11207
PubChem Substance
347829186
ChemSpider
10734

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1CompletedTreatmentSafety1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility5.16 mg/mLALOGPS
logP0.5ALOGPS
logP-0.48ChemAxon
logS-1.3ALOGPS
Physiological Charge0ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area34.14 Å2ChemAxon
Rotatable Bond Count0ChemAxon
Refractivity15.47 m3·mol-1ChemAxon
Polarizability6.95 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available

Taxonomy

Description
This compound belongs to the class of organic compounds known as sulfonyl fluorides. These are compounds containing a sulfonyl (R-S(=O)2-R') functional group singly bonded to a fluorine atom.
Kingdom
Organic compounds
Super Class
Organohalogen compounds
Class
Sulfonyl halides
Sub Class
Sulfonyl fluorides
Direct Parent
Sulfonyl fluorides
Alternative Parents
Sulfonyls / Organosulfonic acids and derivatives / Organic oxides / Hydrocarbon derivatives
Substituents
Sulfonyl / Sulfonyl fluoride / Organosulfonic acid or derivatives / Organic sulfonic acid or derivatives / Organic oxygen compound / Organic oxide / Hydrocarbon derivative / Organosulfur compound / Aliphatic acyclic compound
Molecular Framework
Aliphatic acyclic compounds
External Descriptors
Not Available

Drug created on October 20, 2016 20:30 / Updated on May 01, 2019 11:38